Notably, pharmacological inhibition of CD40 signaling significantly attenuated Fn-aggravated colitis, as evidenced by less body weight loss (Figure 7B), reduced DAI scores (Figure 7C), preserved colon length (Figures 7D, E), and improved histological features (Figures 7F, G). This evidence concerns the gene FN1 and colitis.